Prognostic value of the veterans affairs frailty index in older patients with non-small cell lung cancer

被引:10
|
作者
Cheng, David [1 ,2 ]
Dumontier, Clark [2 ,3 ,4 ]
Sheikh, Ayesha R. [5 ]
La, Jennifer [3 ]
Brophy, Mary T. [3 ,6 ]
Do, Nhan, V [3 ,6 ]
Driver, Jane A. [2 ,3 ,6 ,7 ]
Tuck, David P. [3 ,6 ]
Fillmore, Nathanael R. [2 ,3 ,7 ]
机构
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Harvard Med Sch, Dept Med, Boston, MA USA
[3] VA Boston Healthcare Syst, Boston, MA USA
[4] Brigham & Womens Hosp, Boston, MA 02115 USA
[5] St Vincent Hosp, Worcester, MA 01604 USA
[6] Boston Univ, Boston, MA 02215 USA
[7] Dana Farber Canc Inst, Boston, MA 02115 USA
来源
CANCER MEDICINE | 2022年 / 11卷 / 15期
关键词
electronic health records; frailty; non-small cell lung; prognosis; veterans; COMPREHENSIVE GERIATRIC ASSESSMENT; CARE; ONCOLOGY; ACCUMULATION; MORTALITY; CONSENSUS; SURVIVAL; CURVES; ADULTS;
D O I
10.1002/cam4.4658
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Older patients with non-small cell lung cancer (NSCLC) are a heterogeneous population with varying degrees of frailty. An electronic frailty index such as the Veterans Affairs Frailty Index (VA-FI) can potentially help identify vulnerable patients at high risk of poor outcomes. Methods NSCLC patients >= 65 years old and diagnosed in 2002-2017 were identified using the VA Central Cancer Registry. The VA-FI was calculated using administrative codes from VA electronic health records data linked with Medicare and Medicaid data. We assessed associations between the VA-FI and times to mortality, hospitalization, and emergency room (ER) visit following diagnosis by Kaplan-Meier analysis and multivariable stratified Cox models. We also evaluated the change in discrimination and calibration of reference prognostic models after adding VA-FI. Results We identified a cohort of 42,204 older NSCLC VA patients, in which 55.5% were classified as frail (VA-FI >0.2). After adjustment, there was a strong association between VA-FI and the risk of mortality (HR = 1.23 for an increase of four deficits or, equivalently, an increase of 0.129 on VA-FI, p < 0.001), hospitalization (HR = 1.16 for four deficits, p < 0.001), and ER visit (HR = 1.18 for four deficits, p < 0.001). Adding VA-FI to baseline prognostic models led to statistically significant improvements in time-dependent area under curves and did not have a strong impact on calibration. Conclusion Older NSCLC patients with higher VA-FI have significantly elevated risks of mortality, hospitalizations, and ER visits following diagnosis. An electronic frailty index can serve as an accessible tool to identify patients with vulnerabilities to inform clinical care and research.
引用
收藏
页码:3009 / 3022
页数:14
相关论文
共 50 条
  • [41] Prognostic value of lung immune prognostic index in non-small cell lung cancer patients receiving immune checkpoint inhibitors: a meta-analysis
    Wang, Yi
    Lei, Yu
    Zheng, Delai
    Yang, Yanhui
    Luo, Lei
    Li, Ji
    Xie, Xiaoyang
    PATHOLOGY & ONCOLOGY RESEARCH, 2024, 30
  • [42] The Significance of the Prognostic Nutritional Index in Patients with Completely Resected Non-Small Cell Lung Cancer
    Mori, Shunsuke
    Usami, Noriyasu
    Fukumoto, Koichi
    Mizuno, Tetsuya
    Kuroda, Hiroaki
    Sakakura, Noriaki
    Yokoi, Kohei
    Sakao, Yukinori
    PLOS ONE, 2015, 10 (09):
  • [43] Prognostic value of matrix metalloproteinase 9 expression in patients with non-small cell lung cancer
    Peng, Wen-Jia
    Zhang, Jun-Qing
    Wang, Bing-Xiang
    Pan, Hai-Feng
    Lu, Man-Man
    Wang, Jing
    CLINICA CHIMICA ACTA, 2012, 413 (13-14) : 1121 - 1126
  • [44] Prognostic value of neutrophil to lymphocyte ratio in patients with advanced non-small cell lung cancer
    Koukidou, Sofia
    Charpidou, Andriani
    Vassos, Dimitrios
    Grapsa, Dimitra
    Ampelioti, Sevasti
    Dimakou, Ekaterini
    Bakakos, Petros
    Poulakou, Garyphallia
    Syrigos, Konstantinos
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [45] Prognostic value of hematological inflammatory markers in patients with non-small cell lung cancer.
    Kishi, N.
    Ogura, M.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S764 - S765
  • [46] Prognostic value of selected platelet parameters of patients operated for non-small cell lung cancer
    Lochowski, Mariusz
    Rebowski, Marek
    Chalubinska-Fendler, Justyna
    Zawadzka, Izabela
    Lochowska, Barbara
    Cieslik-Wolski, Bartosz
    Kozak, Jozef
    JOURNAL OF THORACIC DISEASE, 2022, 14 (05) : 1374 - 1383
  • [47] The prognostic value and model construction of inflammatory markers for patients with non-small cell lung cancer
    Xu, Wanting
    Liu, Xinya
    Yan, Ci
    Abdurahmane, Gulinurayi
    Lazibiek, Jiayina
    Zhang, Yan
    Cao, Mingqin
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [48] Prognostic Value of the Pretreatment Peripheral Blood Markers in Patients with Non-Small Cell Lung Cancer
    Markelic, Ivona
    Bitar, Lela
    Seiwerth, Fran
    Cucevic, Branka
    Kukulj, Suzana
    Plestina, Sanja
    Dzubur, Fedza
    Samarzija, Miroslav
    Jakopovic, Marko
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S879 - S879
  • [49] Prognostic Value of Histopathological Response to Preoperative Therapy for the Patients With Non-small Cell Lung Cancer
    Nakayama, Y.
    Nonaka, T.
    Mizoguchi, N.
    Shiomi, M.
    Saito, H.
    Oshita, F.
    Yamada, K.
    Ito, H.
    Nakayama, H.
    Yokose, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S607 - S607
  • [50] Prognostic value of HMGB3 expression in patients with non-small cell lung cancer
    Song, Ning
    Liu, Bao
    Wu, Jian-Ling
    Zhang, Rui-Fang
    Duan, Lin
    He, Wen-Shu
    Zhang, Cong-Min
    TUMOR BIOLOGY, 2013, 34 (05) : 2599 - 2603